These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1255 related items for PubMed ID: 23976938

  • 1. Psychedelics and mental health: a population study.
    Krebs TS, Johansen PØ.
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The association between naturalistic use of psychedelics and co-occurring substance use disorders.
    Rabinowitz J, Lev-Ran S, Gross R.
    Front Psychiatry; 2022; 13():1066369. PubMed ID: 36704738
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Jones GM, Nock MK.
    J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME.
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [Abstract] [Full Text] [Related]

  • 9. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M, Meester M.
    J Psychoactive Drugs; 2012 Oct; 44(5):410-7. PubMed ID: 23457892
    [Abstract] [Full Text] [Related]

  • 10. Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
    Jones G, Arias D, Nock M.
    Sci Rep; 2022 Dec 19; 12(1):21927. PubMed ID: 36535992
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.
    Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D.
    J Psychopharmacol; 2023 Jan 19; 37(1):93-106. PubMed ID: 36601974
    [Abstract] [Full Text] [Related]

  • 14. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.
    Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW.
    J Psychopharmacol; 2015 Mar 19; 29(3):280-8. PubMed ID: 25586402
    [Abstract] [Full Text] [Related]

  • 15. Molecular insights into psychedelic drug action.
    Slocum ST, DiBerto JF, Roth BL.
    J Neurochem; 2022 Jul 19; 162(1):24-38. PubMed ID: 34797943
    [Abstract] [Full Text] [Related]

  • 16. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
    Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA.
    Addict Biol; 2022 Nov 19; 27(6):e13229. PubMed ID: 36301215
    [Abstract] [Full Text] [Related]

  • 17. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century.
    Aday JS, Bloesch EK, Davoli CC.
    J Psychoactive Drugs; 2019 Nov 19; 51(3):210-217. PubMed ID: 30836890
    [Abstract] [Full Text] [Related]

  • 18. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T, Amada N, Jungaberle H, Schecke H, Klein M.
    Int J Drug Policy; 2020 Jan 19; 75():102600. PubMed ID: 31778967
    [Abstract] [Full Text] [Related]

  • 19. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.
    Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ.
    Biomed Pharmacother; 2023 Dec 31; 169():115775. PubMed ID: 37944438
    [Abstract] [Full Text] [Related]

  • 20. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL.
    Psychol Med; 2020 Dec 31; 50(16):2655-2666. PubMed ID: 33143790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.